S phase dependence and involvement of NF-kappaB activating kinase to NF-kappaB activation by camptothecin

Biochemical Pharmacology

Volumn 62, Issue 5, 2001, Pages 603-616

  Habraken, Yvette ^a   Piret, Bernard ^a   Piette, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Camptothecin; DNA damage; NF B; NF B inducing kinase; S phase; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NUCLEAR FACTOR KAPPA B ACTIVATING KINASE; PROTEIN KINASE; PROTEIN SUBUNIT; SERINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE S PHASE; CELL POPULATION; CELL SYNCHRONIZATION; CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL SURVIVAL; DNA; DNA-BINDING PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; NF-KAPPA B; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; S PHASE; SERINE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 0035452254     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00709-2     Document Type: Article

References (61)

1. Mechanism of action of camptothecin
2. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
3. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks
4. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA
5. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff
6. The cell cycle effects of camptothecin
7. Cellular resistance to topoisomerase-targeted drugs: From drug uptake to cell death
8. Cell death induced by topoisomerase-targeted drugs: More questions than answers
9. Down-regulation of DNA replication in extracts of camptothecin-treated cells: Activation of an S-phase checkpoint?
10. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells
11. Targeting double-strand breaks to replicating DNA identifies a subpathway of DSB repair that is defective in ataxia-telangiectasia cells
12. Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts
13. Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells
14. The ATM protein is required for sustained activation of NF-kappaB following DNA damage
15. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events
16. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
17. Is NF-kappaB the sensor of oxidative stress?
18. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress
19. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
20. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
21. The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance
22. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation
23. Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs
24. Multiple signals converging on NF-kappaB
25. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation
26. IkappaB kinase alpha (IKKalpha) regulation of IKKbeta kinase activity
27. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms
28. Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV
29. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
30. IKAP is a scaffold protein of the IkappaB kinase complex
31. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases
32. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
33. Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase
34. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta
35. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation
36. NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase
37. Mammalian cell fusion: Studies on the regulation of DNA synthesis and mitosis
38. Interaction of transcription factors with serum response factor. Identification of the Elk-1 binding surface
39. A novel rapid assay for chloramphenicol acetyltransferase gene expression
40. Pharmacokinetics of the 9-amino and 10,11-methylenedioxy derivatives of camptothecin in mice
41. Bridging the gap: Composition, regulation, and physiological function of the IkappaB kinase complex
42. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappaB activation
43. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
44. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins
45. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor
46. Regulation of DNA binding by Rel/NF-kappaB transcription factors: Structural views
47. The structure of the nuclear factor-kappaB protein-DNA complex varies with DNA-binding site sequence
48. Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation
49. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity
50. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex
51. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
52. The generation of nfkb2 p52: Mechanism and efficiency
53. Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis
54. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome
55. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin
56. Degradation of topoisomerase I induced by topoisomerase I inhibitors is dependent on inhibitor structure but independent of cell death
57. SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage
58. Roles of NF-{kappa}B and 26S proteasome in apoptotic cell death induced by Topoisomerase I and II poisons in human non-small cell lung carcinoma
59. Role of proteasomes in T cell activation and proliferation
60. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal
61. The epidermal growth factor receptor engages RIP (receptor interacting protein) and NIK (NF-κB inducing kinase) to activate NF-κB: Identification of a novel RTK signalosome